THE Objective of This Task Order Supports Niaids Goal to Conduct a Series of Standardized Phase 1 and Phase 2 Trials on Next-Generation Vaccines to Generate Data to Inform Decisions on Which Candidates to Support for Advanced Development
Contract Overview
Contract Amount: $173,281,267 ($173.3M)
Contractor: Leidos Biomedical Research Inc
Awarding Agency: Department of Health and Human Services
Start Date: 2023-06-01
End Date: 2028-05-31
Contract Duration: 1,826 days
Daily Burn Rate: $94.9K/day
Official Description: THE OBJECTIVE OF THIS TASK ORDER SUPPORTS NIAIDS GOAL TO CONDUCT A SERIES OF STANDARDIZED PHASE 1 AND PHASE 2 TRIALS ON NEXT-GENERATION VACCINES TO GENERATE DATA TO INFORM DECISIONS ON WHICH CANDIDATES TO SUPPORT FOR ADVANCED DEVELOPMENT.
Place of Performance
Location: Maryland, 21702
State: Maryland Government Spending